Kim Van derpoorten

Synthesis and Anticonvulsant Activity of 2(3<i>H</i>)-Benzoxazolone and 2(3<i>H</i>)-Benzothiazolone Derivatives

Huseyin Ucar, Kim Van derpoorten, S. Cacciaguerra et al. · Journal of Medicinal Chemistry · 1998 · 137 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Derivatives +15

<i>N</i>-Succinyl-(β-alanyl-<scp>l</scp>-leucyl-<scp>l</scp>-alanyl-<scp>l</scp>-leucyl)doxorubicin:  An Extracellularly Tumor-Activated Prodrug Devoid of Intravenous Acute Toxicity

Anne-Marie Fernandez, Kim Van derpoorten, Luc Dasnois et al. · Journal of Medicinal Chemistry · 2001 · 76 citations

Pharmaceutical Science, Intravenous Administration, Immunology +19

Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies.

André Trouet, A. Passioukov, Kim Van derpoorten et al. · PubMed · 2001 · 68 citations

Good Blood Stability, Immunology, Tumor Biology +16

Anti-HIV activity of N-1-adamantyl-4-aminophthalimide

Kim Van derpoorten, Jan Balzarini, Erik De Clercq et al. · Biomedicine & Pharmacotherapy · 1997 · 50 citations

Medicinal Chemistry, Anti-hiv Activity, Medicine +6

2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: Novel, potent and selective σ1 receptor ligands

H. UCAR, S. Cacciaguerra, Santi Spampinato et al. · European Journal of Pharmacology · 1997 · 31 citations

Medicinal Chemistry, -Benzothiazolone Derivatives, Medicine +8